Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00840528 · ClinicalTrials.gov registry record · NA

Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT00840528 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00840528, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

The principal purpose of this study is to identify hyper-responsive, responsive and non-responsive groups of healthy human subjects based on their airway neutrophilic response to ozone exposure, and to perform micro-array analyses on DNA collected from recovered airway cells to explore possible differences in gene expression profiles between the three groups

Interventions

  • OTHER ozone

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2002-02
Est. Completion 2017-06-20
Phase NA

What the Registry Record Tells You About NCT00840528

The ClinicalTrials.gov registry entry for NCT00840528 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ozone is the first listed.

NCT00840528 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00840528 about?

NCT00840528 is a clinical study titled "Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans". The principal purpose of this study is to identify hyper-responsive, responsive and non-responsive groups of healthy human subjects based on their airway neutrophilic response to ozone exposure, and to perform micro-array analyses on DNA collected from recovered airway cells to explore possible diff...

What is the current status of trial NCT00840528?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2002-02. Estimated completion is 2017-06-20.

What interventions are being tested in trial NCT00840528?

The interventions under investigation include: ozone (OTHER).

Who is sponsoring clinical trial NCT00840528?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.